Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study

Abstract The study hypothesis was that fasting glucose, insulin, fructosamine, C-reactive protein, and interleukin-6 decrease and adiponectin increases with daily flaxseed consumption in overweight or obese individuals with pre-diabetes. In this randomized, cross-over study overweight or obese men and postmenopausal women (n = 25) with pre-diabetes consumed 0, 13, or 26 g ground flaxseed for 12 weeks. Glucose, insulin, homeostatic model assessment (HOMA-IR), and normalized percent of α-linolenic fatty acid (ALA) were significantly different by treatment (multiple analysis of variance, P = .036, P = .013, P = .008, P = .024 respectively). Paired t tests showed glucose decreased on the 13 g intervention compared to the 0 g period [13g = −2.10 ± 1.66 mg/L (mean ± SEM), 0 g=9.22 ± 4.44 mg/L, P = .036]. Insulin decreased on the 13 g intervention but not the 26 g ( P = .021) and 0 g ( P = .013) periods (13 g=−2.12 ± 1.00 mU/L, 26 g=0.67 ± 0.84 mU/L, 0g=1.20 ± 1.16 mU/L). HOMA-IR decreased on the 13 g period but not on the 26 g ( P = .012) and 0 g ( P = .008) periods (13g = −0.71 ± 0.31, 26g=0.27 ± 0.24, 0g=0.51 ± 0.35). The α-linolenic fatty acid decrease for the 0 g period was different than the 13 g ( P = .024) and 26 g ( P = .000) periods (13 g=0.20 ± 0.04, 26g=0.35 ± 0.07, 0g=−0.01 ± 0.07). Fructosamine, high sensitivity C-reactive protein, adiponectin, and high-sensitivity interleukin-6 had no significant differences. Flaxseed intake decreased glucose and insulin and improved insulin sensitivity as part of a habitual diet in overweight or obese individuals with pre-diabetes.